A Harvey Nash / KPMG CIO Survey 2020 industry report
Operational priorities, technology investments, business performance, cloud and data security, diversity and inclusion in Life Sciences
Historically, given the fundamental societal need for medicines regardless of economic conditions, the Life Sciences sector has been largely resistant to recessions—and has also generally been less severely impacted than other sectors by COVID-19. Indeed, in many ways the pandemic has put the industry into ‘surge’ mode. Companies are experiencing high demand for select products and have even been forced to discontinue some of their initiatives to focus on producing critical supply for COVID-19 management and treatment, and medical technologies that best position Life Sciences for the new reality.
In this Life Sciences report, we share how being a digital leader differentiates you from your industry peers. We also compare survey results for Life Sciences to overall results in these key areas:
- board priorities and investment
- strategy and operating model
- delivering value at speed
- people and culture
- the rise of cyber
- analytics and insight.
If you would like to learn more, we would be happy to discuss the survey findings and our analysis in more detail.
